Critical Role of IRF-8 in Negative Regulation of TLR3 Expression by Src Homology 2 Domain-Containing Protein Tyrosine Phosphatase-2 Activity in Human Myeloid Dendritic Cells

被引:24
|
作者
Fragale, Alessandra [1 ]
Stellacci, Emilia [1 ,2 ]
Ilari, Ramona [1 ]
Remoli, Anna Lisa [1 ]
Lanciotti, Angela [1 ,3 ]
Perrotti, Edvige [1 ]
Shytaj, Iart [1 ]
Orsatti, Roberto [1 ]
Lawrence, Harshani R. [4 ]
Lawrence, Nicholas J. [4 ]
Wu, Jerry [4 ]
Rehli, Michael [5 ]
Ozato, Keiko [6 ]
Battistini, Angela [1 ]
机构
[1] Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, I-00161 Rome, Italy
[2] Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, I-00161 Rome, Italy
[3] Ist Super Sanita, Dipartimento Biol Cellulare & Neurosci, I-00161 Rome, Italy
[4] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[5] Univ Hosp, Dept Hematol & Oncol, Regensburg, Germany
[6] NICHHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20814 USA
来源
JOURNAL OF IMMUNOLOGY | 2011年 / 186卷 / 04期
基金
美国国家卫生研究院;
关键词
SEQUENCE-BINDING-PROTEIN; TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; IMMUNE-RESPONSE; I INTERFERON; ICSBP; TRANSCRIPTION; ACTIVATION; VIRUS; MICE;
D O I
10.4049/jimmunol.1000918
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Despite extensive studies that unraveled ligands and signal transduction pathways triggered by TLRs, little is known about the regulation of TLR gene expression. TLR3 plays a crucial role in the recognition of viral pathogens and induction of immune responses by myeloid DCs. IFN regulatory factor (IRF)-8, a member of the IRF family, is a transcriptional regulator that plays essential roles in the development and function of myeloid lineage, affecting different subsets of myeloid DCs. In this study, we show that IRF-8 negatively controls TLR3 gene expression by suppressing IRF-1- and/or polyinosinic-polycytidylic acid-stimulated TLR3 expression in primary human monocyte-derived DCs (MDDCs). MDDCs expressed TLR3 increasingly during their differentiation from monocytes to DCs with a peak at day 5, when TLR3 expression was further enhanced upon stimulation with polyinosinic-polycytidylic acid and then was promptly downregulated. We found that both IRF-1 and IRF-8 bind the human TLR3 promoter during MDDC differentiation in vitro and in vivo but with different kinetic and functional effects. We demonstrate that IRF-8-induced repression of TLR3 is specifically mediated by ligand-activated Src homology 2 domain-containing protein tyrosine phosphatase association. Indeed, Src homology 2 domain-containing protein tyrosine phosphatase-dephosphorylated IRF-8 bound to the human TLR3 promoter competing with IRF-1 and quashing its activity by recruitment of histone deacetylase 3. Our findings identify IRF-8 as a key player in the control of intracellular viral dsRNA-induced responses and highlight a new mechanism for negative regulation of TLR3 expression that can be exploited to block excessive TLR activation. The Journal of Immunology, 2011, 186: 1951-1962.
引用
收藏
页码:1951 / 1962
页数:12
相关论文
共 50 条
  • [31] Predominant expression of the src homology 2-containing tyrosine phosphatase protein SHP2 in vascular smooth muscle cells
    Masaaki Adachi
    Hiroaki Iwaki
    Masanobu Shindoh
    Yukihiro Akao
    Takahisa Hachiya
    Masako Ikeda
    Virchows Archiv, 1997, 430 : 321 - 325
  • [32] Regulation of Src homology 2-containing protein tyrosine phosphatase by advanced glycation end products: the role on atherosclerosis in diabetes
    Seki, Naoto
    Hashimoto, Naotake
    Taira, Masato
    Yagi, Sayaka
    Yoshida, Yuriko
    Ishikawa, Kou
    Suzuki, Yoshifumi
    Sano, Hiroyuki
    Horiuchi, Seikou
    Yoshida, Shouji
    Sakurai, Kenichi
    Yagui, Kazuo
    Makino, Hideichi
    Saito, Yasushi
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2007, 56 (11): : 1591 - 1598
  • [33] Predominant expression of the src homology 2-containing tyrosine phosphatase protein SHP2 in vascular smooth muscle cells
    Adachi, M
    Iwaki, H
    Shindoh, M
    Akao, Y
    Hachiya, T
    Ikeda, M
    Hinoda, Y
    Imai, K
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1997, 430 (04): : 321 - 325
  • [34] Decreased expression of Src homology 2 domain-containing protein tyrosine phosphatase 1 reduces T cell activation threshold but not the severity of experimental autoimmune myasthenia gravis
    Deng, CS
    Wu, B
    Yang, H
    Hussain, RZ
    Lovett-Racke, AE
    Christadoss, P
    Racke, MK
    JOURNAL OF NEUROIMMUNOLOGY, 2003, 138 (1-2) : 76 - 82
  • [35] Regulation of peripheral and central immunity: Understanding the role of Src homology 2 domain-containing tyrosine phosphatases, SHP-1 & SHP-2
    Garg, Manika
    Wahid, Mohd
    Khan, Farah
    IMMUNOBIOLOGY, 2020, 225 (01)
  • [36] IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1
    Taylor, Alison
    Akdis, Muebeccel
    Joss, Andrea
    Akkoç, Tunç
    Wenig, Renate
    Colonna, Marco
    Daigle, Isabelle
    Flory, Egbert
    Blaser, Kurt
    Akdis, Cezmi A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (01) : 76 - 83
  • [37] Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells
    Yusa, S
    Campbell, KS
    JOURNAL OF IMMUNOLOGY, 2003, 170 (09): : 4539 - 4547
  • [38] Expression of dominant-negative Src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation
    Dustin, LB
    Plas, DR
    Wong, J
    Hu, YHT
    Soto, C
    Chan, AC
    Thomas, ML
    JOURNAL OF IMMUNOLOGY, 1999, 162 (05): : 2717 - 2724
  • [39] Regulation of the Src Homology 2 Domain-containing Inositol 5′-Phosphatase (SHIP1) by the Cyclic AMP-dependent Protein Kinase
    Zhang, Jun
    Walk, Scott F.
    Ravichandran, Kodi S.
    Garrison, James C.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (30) : 20070 - 20078
  • [40] Association between diversity in the Src homology 2 domain-containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer
    Azuma, T
    Yamazaki, S
    Yamakawa, A
    Ohtani, M
    Muramatsu, A
    Suto, H
    Ito, Y
    Dojo, M
    Yamazaki, Y
    Kuriyama, M
    Keida, Y
    Higashi, H
    Hatakeyama, M
    JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (05): : 820 - 827